Stem cell technologies INC. Reagents and consumables

Ended Purchase Order Awarded

Contract number
75N90024P00037
Awardee
Awarding agency
Obligated
$36,029

Award facts

Contract value 100% obligated
$36,028.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Kent, WA 98032, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institutes of Health Clinical Center awarded Stemcell Technologies Inc. a firm fixed-price purchase order valued at thirty-six thousand twenty-eight dollars and eighty cents ($36,028.80) to provide reagents and consumables. As the parent company, Stemcell Technologies will perform under the contract through its Kent, Washington facility from November 1st through December 1st, 2023. The Clinical Center, a component of the Department of Health and Human Services' National Institutes of Health focused on clinical research, issued this contract to procure products that will likely support the agency's stem cell research efforts. No subcontractors or set-aside designations were identified.

Quick answers

Who was awarded contract 75N90024P00037?

75N90024P00037 was awarded to Stemcell Technologies Inc. by NIH Clinical Center (National Institutes of Health) on November 1, 2023.

How much is contract 75N90024P00037 worth?

The government has obligated $36,029 on 75N90024P00037.

Was contract 75N90024P00037 competed?

The extent of competition for 75N90024P00037 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award